Garner Todd W's Form 4 filing
CONMED Corp (CNMD) · filed Oct 5, 2021
- Accession no.
- 0001127602-21-026746
- Filed
- Oct 5, 2021
- Trade date
- Oct 4, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.12M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Garner Todd WCIK 0001726884 | Officer (Executive Vice President & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | SSaleDisposed | −58 | $129.33F1 | −$7,501.14 | 133 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −81 | $130.13F2 | −$10,540.53 | 52 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −20 | $131.63F3 | −$2,632.6 | 32 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −32 | $132.99F4 | −$4,255.68 | 0 | Direct | |
| Oct 4, 2021 | Common Stock | MOption exerciseAcquired | +8,400 | $50.61 | +$425,124 | 8,400 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −3,117 | $129.38F6 | −$403,277.46 | 5,283 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −3,083 | $130.05F7 | −$400,944.15 | 2,200 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −800 | $131.49F8 | −$105,192 | 1,400 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −900 | $132.65F9 | −$119,385 | 500 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −500 | $133.45F10 | −$66,725 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | MOption exerciseDisposed | −8,400 | $0.00 | $0 | 39,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.75 to $129.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.34 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.79 to $133.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.72 to $129.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.92 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.11 to $133.10. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.13 to $133.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.